SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-31
👔
Alzamend Neuro, Inc.
@ALZN_InsiderForm 4 Filing: AULT MILTON C III Buys $111K of $ALZN
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Alzamend Neuro, Inc.
Ticker: $ALZN
Transaction Value
$111K
Price/Share: $1.01
transaction date
2026-04-14
Shares: 110,388
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, AULT MILTON C III, holds the title of Director at Alzamend Neuro, Inc..
On 2026-04-14, the insider transacted 110,388 shares.The shares were transacted at a weighted average price of $1.01 per share, resulting in a total market-relevant value of $111K.
Executive Summary Summary
AULT MILTON C III (Director) bought $111K of $ALZN
Post-Transaction Position: 116,648 shares
SEC Accession No: 0001214659-26-011111 (CIK: 1212502)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.